Evaluation of neonatal hearing screening results of newborns with premature retinopathy

Objectives: To reveal the risk situations of ROP patients in terms of hearing loss by examining the newborn hearing screening test results. Methods: Hearing screening test results of ROP patients and newborns with similar congenital risk factors(control group) treated in our hospital were retrospectively screened. Both groups were compared in terms of newborn hearing screening test results. Results: In the first screening test, the rate of refer result in the ROP group was significantly higher than the control group (p < 0.05). There was no significant difference between the two groups in terms of second hearing screening test results (p > 0.05). In the second screening test, 100% of stage 3 ROP patients failed from the right ear and 80% in the left ear, and this difference was statistically significant compared to the other two groups (p < 0.05). Conclusion: Newborn hearing screenings of patients with advanced stage ROP patients should be followed up more sensitively, since stage 3 ROP patients had more failure results from the screening test in our study.

Automated summary

The study revealed that ROP patients have higher risk of hearing loss in newborn hearing screening, especially in stage 3 ROP patients. It is recommended to follow up the newborn hearing screenings of patients with advanced stage ROP more sensitively.